Innomune 50mg 10 Tablets

Babies: It is not applicable for babies. Lactating mother: It is unsafe during breastfeeding.
Limited human studies suggest that the drug may pass into the breastmilk and harm the baby Pregnancy: It is unsafe to use this medicine during pregnancy. Limited human studies have shown harmful effects on the developing baby.
Seek doctor advice before using this medication. Driving: Innomune tablet may cause blurred vision for a short time just after its use. Do not drive until your vision is clear. Alcohol: It is unknown whether it is safe to consume alcohol with innomune tablets.
Seek doctor advice before using this medication. Kidney: Innomune tablets should use with caution in patients with kidney disease. Dosage adjustment is needed.
Seek doctor advice before using this medication. Liver: Innomune tablets should use with caution in patients with liver disease. Dosage adjustment is needed.
Seek doctor advice before using this medication. These patients can experience low blood sugar levels that may become normal after a long time..

Nausea decreased white blood cell count Increased bleeding tendency Infection Loss of appetite.

Innomune tablet is an immunosuppressant. It works by reducing the action of the immune system and prevents rejection of the transplanted organ.
It also blocks certain chemical messengers responsible for inflammation, swelling, and redness associated with certain joint diseases..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Your doctor may prescribe innomune tablets to stop the body from rejecting transplanted organs • Innomune tablets relieve joint pain and inflammation in rheumatoid arthritis • You may have to take combination medications along with innomune tablets for better relief of symptoms • Avoid contact with people who have a cold, flu, or other contagious illness. Inform your doctor if you have any signs of infection such as a fever or sore throat • Inform your doctor if you are pregnant or planning to conceive or breastfeeding.

Contraindicated • Innomune + Fiboxostat: Concurrent use leads to increase in the levels of innomune by decreasing metabolism Serious • Innomune + Adalimumab: Concurrent use leads to increased immunosuppressive effects • Innomune + Alefacept: Concurrent use leads to increased immunosuppressive effects Monitor closely • Innomune + Antithrombin alfa: Concurrent use leads to decrease in the effects of antithrombin alfa by an unknown mechanism • Innomune + Argatroban: Concurrent use leads to decrease in the effects of argatroban by an unknown mechanism.